DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Bulletin > Acta Medica Nagasakiensia > Volume 30, No. 4 >

Prevention and Control of HBV Infection

File Description SizeFormat
acta30_04_08_t.pdf287.15 kBAdobe PDFView/Open

Title: Prevention and Control of HBV Infection
Authors: Yano, Michitami
Issue Date: 20-Mar-1986
Citation: Acta medica Nagasakiensia. 1986, 30(4), p.312-316
Abstract: HB Vaccine in Japan In Japan, there are three companies which concern themselves in the development of HB Vaccine. Regarding the Vaccines developed by Kitasato Institute and Green Cross co., the licence was given by Ministry of Health and Welfare. After the safety test using Chimpanzees, these two HB Vaccines are going to be on the market and available around the end of 1985. The HB Vaccine developed by Kaketsuken Institute is now asking for the licence of it. Each Vaccine produced by three companies is made from e-Antigen negative Plasma, and it was inactivated by formaline after 10 hrs' heat. sterilization at 60 degrees. The subtype of HBs Antigen of source plasma is adr, and 40μg of HBs Antigen is contained in 1ml of HB Vaccine. One dose of each Vaccine is 0.5ml for adult and 0.25 ml for babies and administrated subcutaneously. The producing method and Alminum content as an adjunct are different in these 3 Vaccines. (Table 1) The positive ratio of anti HBs reaches maximum point after 3rd vaccination, and the mean titer of anti HBs
URI: http://hdl.handle.net/10069/15696
ISSN: 00016055
Type: Departmental Bulletin Paper
Text Version: publisher
Appears in Collections:Volume 30, No. 4

Citable URI : http://hdl.handle.net/10069/15696

All items in NAOSITE are protected by copyright, with all rights reserved.


Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace